This article is a related article to the magazine "Ryo Kinoshita's Direction in 'Taiyo ni Hoero!'" ******************************************************Introduction: Clues to Exploring Team A and ...

A finely ground powder of the traditional Chinese herb Astragalus membranaceus significantly boosted the complement regulator C4bp and antibody IgM in weaned goat kids without triggering inflammation, ...

Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the ...

Stocks that have been relatively strong in the past may continue to show strength for some time afterward. This is the ...

Paroxysmal nocturnal hemoglobinuria has long been one of hematology’s cruelest puzzles: a rare, acquired stem-cell mutation that leaves red blood cells defenseless against the body’s own com ...

The Jets failed to get the job done in Week 3, but in defeat, Aaron Glenn & Co. learned just how much of a force their tight end room can be.

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and is a major contributor to the global burden of chronic kidney disease. Strong evidence highlights complement ...

Ionis Pharmaceuticals Inc. and partner Roche announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA ...

NVCT stock surged on NXP100 PNH deal. Explore catalysts, dilution risk, and pipeline outlook for NXP100/NXP200/NXP900—read the NVCT hold thesis now.

Opportunities center on targeted complement inhibitors, biologics, small molecules, RNA and gene therapies for rare diseases across ophthalmology, hematology and immunology.Dublin, Sept. 16, 2026 ...